Today’s Research Reports on Trending Tickers: Endo International and Sangamo Therapeutics
U.S. markets rebounded Thursday on the strength of the financial and technology sectors. The Dow Jones Industrial Average jumped 0.41 percent to close at 24,216.05, while the S&P 500 Index spiked 0.62 percent to close at 2,716.31. The Nasdaq Composite Index jumped 0.79 percent to close at 7,503.68. Shares of Bank of America, Citigroup, Goldman Sachs, J.P. Morgan and Morgan Stanley all posted gains of over 1 percent to lift the financial sector higher on Thursday.
“After 13 straight days of declines, financials finally bounced back. It’s good to see the leadership from this sector,” said Lindsey Bell, investment strategist at CFRA, according to MarketWatch. “Given the current environment when there lots of uncertainty surrounding global trade, investors continue to go to growth, such as technology shares and domestic stocks such as small-caps. Despite recent rotation, there has not been a real change in this sentiment,” Bell said.
RDI Initiates Coverage on:
Endo International plc
Sangamo Therapeutics, Inc.
Endo International’s stock jumped 7.9% Thursday, to close the day at $9.83. The stock recorded a trading volume of 7,082,650 shares, which was above its three months average volume of 6,328,304 shares. In the last year, Endo International’s shares have traded in a range of 5.27 – 12.54. The share price has gained 86.53% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $7.39 is above its 200-day moving average of $6.92. Shares of Endo International have gained roughly 55.78 percent in the past month and are up 26.84 percent year-to-date.
Access RDI’s Endo International plc Research Report at:
On Thursday, shares of Sangamo Therapeutics recorded a trading volume of 2,703,330 shares, which was above the three months average volume of 2,564,440 shares. The stock ended the day 0.71% lower at $13.90. The share price has fallen 49.45% from its 52 week high with a 52 week trading range of 8.00 – 27.50. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $15.91 is below its 200-day moving average of $18.75. Shares of Sangamo Therapeutics have fallen roughly 10.90 percent in the past month and are down 15.24 percent year-to-date.
Access RDI’s Sangamo Therapeutics, Inc. Research Report at:
Our Actionable Research on Endo International plc (NASDAQ:ENDP) and Sangamo Therapeutics, Inc. (NASDAQ:SGMO) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.